Mirae Asset Global Etfs Holdings Ltd. Beam Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 117,446 shares of BEAM stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,446
Previous 167,014
29.68%
Holding current value
$3.02 Million
Previous $3.26 Million
38.76%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$258 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$250 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$228 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$197 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$122 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.81B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...